Kwak Yoon Hae, Kwak Dae-Kyung, Moon Hyun-Soo, Kim Nan Young, Yee Jae-Sung, Yoo Je-Hyun
Division of Orthopaedic Surgery, Severance Children's Hospital, Yonsei University College of Medicine, Seoul 03722, Korea.
Department of Orthopaedic Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Korea.
Diagnostics (Basel). 2021 Feb 7;11(2):258. doi: 10.3390/diagnostics11020258.
High tibial osteotomy (HTO) is an effective alternative for medial compartmental knee osteoarthritis (OA). Circulating microRNAs (miRNAs) are known to serve as OA-related biomarkers. The present study investigated the differential expression of serum miRNAs before and after HTO to identify potential miRNAs as prognostic biomarkers. miRNA-polymerase chain reaction (PCR) arrays were used to screen for miRNAs in the serum at preoperative and 6-month postoperative time points from six patients, and the differentially expressed miRNAs identified in the profiling stage were validated using real-time PCR at post-operative months 6 and 18 in 27 other HTO-treated patients. Among 84 miRNAs involved in the inflammatory process, three (miR-19b-3p, miR-29c-3p, and miR-424-5p) showed differential expression patterns in the profiling stage ( = 0.011, 0.015, and 0.021, respectively). Levels of these three and four other miRNAs (miR-140-3p, miR-454-3p, miR-let-7e-5p, and miR-885-5p) known to be related to OA progression were evaluated in the serum of 27 patients. Only four miRNAs (miR-19b-3p, miR-140-3p, miR-454-3p, and miR-let-7e-5p) were significantly upregulated at postoperative month 6 ( = 0.003, 0.005, 0.004, and 0.004, respectively), and only miR-140-3p was significantly upregulated up to 18 months after operation ( = 0.003). Together, this study reveals the significantly upregulated serum miRNAs after HTO as potential prognostic biomarkers; however, further studies are warranted to elucidate their clinical implications.
高位胫骨截骨术(HTO)是治疗膝关节内侧间室骨关节炎(OA)的一种有效替代方法。已知循环微小RNA(miRNA)可作为与OA相关的生物标志物。本研究调查了HTO前后血清miRNA的差异表达,以确定潜在的miRNA作为预后生物标志物。使用miRNA聚合酶链反应(PCR)阵列对6例患者术前和术后6个月时血清中的miRNA进行筛选,并在另外27例接受HTO治疗的患者术后6个月和18个月时使用实时PCR对在分析阶段鉴定出的差异表达miRNA进行验证。在参与炎症过程的84种miRNA中,有三种(miR-19b-3p、miR-29c-3p和miR-424-5p)在分析阶段呈现出差异表达模式(分别为P = 0.011、0.015和0.021)。在27例患者的血清中评估了这三种以及另外四种已知与OA进展相关的miRNA(miR-140-3p、miR-454-3p、miR-let-7e-5p和miR-885-5p)的水平。仅四种miRNA(miR-19b-3p、miR-140-3p、miR-454-3p和miR-let-7e-5p)在术后6个月时显著上调(分别为P = 0.003、0.005、0.004和0.004),并且只有miR-140-3p在术后18个月时仍显著上调(P = 0.003)。总之,本研究揭示了HTO后血清miRNA显著上调作为潜在的预后生物标志物;然而,需要进一步研究以阐明它们的临床意义。